These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7322253)

  • 21. Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin.
    Férnandez A; Hortal L; Rodríguez JC; Vega N; Plaza C; Palop L
    Am J Nephrol; 1991; 11(1):12-5. PubMed ID: 2048573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new label for erythropoiesis stimulating agents: the FDA'S sentence.
    Fishbane S; Jhaveri KD
    Semin Dial; 2012 May; 25(3):263-6. PubMed ID: 22515844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of mesterolone on erythropoiesis of chronically haemodialysed patients (author's transl)].
    Kraft D; Freund D; Karow J
    Dtsch Med Wochenschr; 1974 May; 99(21):1119-25. PubMed ID: 4210547
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A beneficial effect of the in situ kidney on in vitro marrow erythropoiesis in chronic renal failure.
    Ortega JA; Malekzadeh MH; Dukes PP; Pennisi AV; Fine RN; Ma A; Shore NA
    Nephron; 1979; 23(4):169-73. PubMed ID: 471139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dosage of erythropoietin in children treated with hemodialysis and continuous ambulatory peritoneal dialysis].
    Sieniawska M; Roszkowska-Blaim M
    Pediatr Pol; 1995 Dec; 70(12):1023-8. PubMed ID: 8649941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Erythropoiesis in anephric patients].
    Blumberg A; Keller H
    Schweiz Med Wochenschr; 1971 Dec; 101(52):1887-93. PubMed ID: 5141281
    [No Abstract]   [Full Text] [Related]  

  • 28. Is there a dissociation of erythropoietic proliferation and serum erythropoietin levels in renal failure patients on longterm haemodialysis treatment.
    Walle AJ; Niedermayer W
    Proc Eur Dial Transplant Assoc; 1980; 17():162-6. PubMed ID: 7243765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoiesis in anephric or kidney transplanted patients.
    Nakao K; Takaku F; Chiba S
    Isr J Med Sci; 1971; 7(7):986-90. PubMed ID: 4943623
    [No Abstract]   [Full Text] [Related]  

  • 30. Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Marcelli D; Bayh I; Merello JI; Ponce P; Heaton A; Kircelli F; Chazot C; Di Benedetto A; Marelli C; Ladanyi E; Kroczak M; Stuard S; Grassmann A; Scatizzi L; Brand K; Canaud B
    Kidney Int; 2016 Jul; 90(1):192-202. PubMed ID: 27178833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiological characteristics of anemia in patients periodically dialyzed].
    Antonov S
    Vutr Boles; 1985; 24(2):13-8. PubMed ID: 3898583
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current issues in erythropoietin therapy of renal anemia].
    Zakar G
    Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin treatment: influence of haemoglobin concentration on dialyser creatinine clearance in haemodialysed patients.
    Zehnder C
    Nephron; 1989; 51(3):424-5. PubMed ID: 2918959
    [No Abstract]   [Full Text] [Related]  

  • 34. Chapter 8 Haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2010: national and centre-specific analyses.
    Webb L; Gilg J; Wilkie M
    Nephron Clin Pract; 2012; 120 Suppl 1():c145-74. PubMed ID: 22964566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.
    Davidkova S; Prestidge TD; Reed PW; Kara T; Wong W; Prestidge C
    Pediatr Nephrol; 2016 May; 31(5):819-26. PubMed ID: 26667237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin inhibitor in plasma from patients with chronic renal failure.
    Moriyama Y; Saito H; Kinoshita Y
    Haematologia (Budap); 1970; 4(1):15-20. PubMed ID: 5522355
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement of erythropoiesis in uremic patients on CAPD.
    Lamperi S; Carozzi S; Icardi A
    Int J Artif Organs; 1983 Jul; 6(4):191-4. PubMed ID: 6629524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroconversion rate, hepatitis B vaccination, hemodialysis, and zinc supplementation.
    Rawer P; Willems WR; Breidenbach T; Guttmann W; Pabst W; Schütterle G
    Kidney Int Suppl; 1987 Oct; 22():149-52. PubMed ID: 3481000
    [No Abstract]   [Full Text] [Related]  

  • 39. Candidate biomarkers for erythropoietin response in end-stage renal disease.
    Besarab A; Yee J
    Kidney Int; 2011 Mar; 79(5):488-90. PubMed ID: 21321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anemia in terminal kidney failure. Pathogenesis and therapy].
    Heilmann E
    Fortschr Med; 1977 Feb; 95(6):338-44. PubMed ID: 838456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.